242 related articles for article (PubMed ID: 23716398)
1. Rescue of cardiomyopathy through U7snRNA-mediated exon skipping in Mybpc3-targeted knock-in mice.
Gedicke-Hornung C; Behrens-Gawlik V; Reischmann S; Geertz B; Stimpel D; Weinberger F; Schlossarek S; Précigout G; Braren I; Eschenhagen T; Mearini G; Lorain S; Voit T; Dreyfus PA; Garcia L; Carrier L
EMBO Mol Med; 2013 Jul; 5(7):1128-45. PubMed ID: 23716398
[TBL] [Abstract][Full Text] [Related]
2. Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice.
Stöhr A; Friedrich FW; Flenner F; Geertz B; Eder A; Schaaf S; Hirt MN; Uebeler J; Schlossarek S; Carrier L; Hansen A; Eschenhagen T
J Mol Cell Cardiol; 2013 Oct; 63():189-98. PubMed ID: 23896226
[TBL] [Abstract][Full Text] [Related]
3. Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.
Flenner F; Geertz B; Reischmann-Düsener S; Weinberger F; Eschenhagen T; Carrier L; Friedrich FW
J Physiol; 2017 Jun; 595(12):3987-3999. PubMed ID: 28090637
[TBL] [Abstract][Full Text] [Related]
4. Adrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in mice.
Schlossarek S; Schuermann F; Geertz B; Mearini G; Eschenhagen T; Carrier L
J Muscle Res Cell Motil; 2012 May; 33(1):5-15. PubMed ID: 22076249
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of human myosin-binding protein C3 variants associated with hypertrophic cardiomyopathy reveals exon-specific cardiac phenotypes in zebrafish model.
Da'as SI; Yalcin HC; Nasrallah GK; Mohamed IA; Nomikos M; Yacoub MH; Fakhro KA
J Cell Physiol; 2020 Nov; 235(11):7870-7888. PubMed ID: 31943169
[TBL] [Abstract][Full Text] [Related]
6. Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice.
Fraysse B; Weinberger F; Bardswell SC; Cuello F; Vignier N; Geertz B; Starbatty J; Krämer E; Coirault C; Eschenhagen T; Kentish JC; Avkiran M; Carrier L
J Mol Cell Cardiol; 2012 Jun; 52(6):1299-307. PubMed ID: 22465693
[TBL] [Abstract][Full Text] [Related]
7. Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.
Goyenvalle A; Babbs A; Wright J; Wilkins V; Powell D; Garcia L; Davies KE
Hum Mol Genet; 2012 Jun; 21(11):2559-71. PubMed ID: 22388933
[TBL] [Abstract][Full Text] [Related]
8. Engineering U7snRNA gene to reframe transcripts.
Goyenvalle A
Methods Mol Biol; 2012; 867():259-71. PubMed ID: 22454067
[TBL] [Abstract][Full Text] [Related]
9. MYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correction.
Behrens-Gawlik V; Mearini G; Gedicke-Hornung C; Richard P; Carrier L
Pflugers Arch; 2014 Feb; 466(2):215-23. PubMed ID: 24337823
[TBL] [Abstract][Full Text] [Related]
10. Muscle function recovery in golden retriever muscular dystrophy after AAV1-U7 exon skipping.
Vulin A; Barthélémy I; Goyenvalle A; Thibaud JL; Beley C; Griffith G; Benchaouir R; le Hir M; Unterfinger Y; Lorain S; Dreyfus P; Voit T; Carlier P; Blot S; Garcia L
Mol Ther; 2012 Nov; 20(11):2120-33. PubMed ID: 22968479
[TBL] [Abstract][Full Text] [Related]
11. Activation of Autophagy Ameliorates Cardiomyopathy in
Singh SR; Zech ATL; Geertz B; Reischmann-Düsener S; Osinska H; Prondzynski M; Krämer E; Meng Q; Redwood C; van der Velden J; Robbins J; Schlossarek S; Carrier L
Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29021349
[TBL] [Abstract][Full Text] [Related]
12. Targeted skipping of a single exon harboring a premature termination codon mutation: implications and potential for gene correction therapy for selective dystrophic epidermolysis bullosa patients.
Goto M; Sawamura D; Nishie W; Sakai K; McMillan JR; Akiyama M; Shimizu H
J Invest Dermatol; 2006 Dec; 126(12):2614-20. PubMed ID: 16778792
[TBL] [Abstract][Full Text] [Related]
13. Selective phosphorylation of PKA targets after β-adrenergic receptor stimulation impairs myofilament function in Mybpc3-targeted HCM mouse model.
Najafi A; Sequeira V; Helmes M; Bollen IA; Goebel M; Regan JA; Carrier L; Kuster DW; Van Der Velden J
Cardiovasc Res; 2016 May; 110(2):200-14. PubMed ID: 26825555
[TBL] [Abstract][Full Text] [Related]
14. How do MYBPC3 mutations cause hypertrophic cardiomyopathy?
Marston S; Copeland O; Gehmlich K; Schlossarek S; Carrier L
J Muscle Res Cell Motil; 2012 May; 33(1):75-80. PubMed ID: 22057632
[TBL] [Abstract][Full Text] [Related]
15. Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice.
Mearini G; Stimpel D; Geertz B; Weinberger F; Krämer E; Schlossarek S; Mourot-Filiatre J; Stoehr A; Dutsch A; Wijnker PJ; Braren I; Katus HA; Müller OJ; Voit T; Eschenhagen T; Carrier L
Nat Commun; 2014 Dec; 5():5515. PubMed ID: 25463264
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of a truncating and a missense MYBPC3 mutation on contractile parameters of engineered heart tissue.
Wijnker PJ; Friedrich FW; Dutsch A; Reischmann S; Eder A; Mannhardt I; Mearini G; Eschenhagen T; van der Velden J; Carrier L
J Mol Cell Cardiol; 2016 Aug; 97():82-92. PubMed ID: 27108529
[TBL] [Abstract][Full Text] [Related]
17. The assembly and evaluation of antisense oligonucleotides applied in exon skipping for titin-based mutations in dilated cardiomyopathy.
Hahn JK; Neupane B; Pradhan K; Zhou Q; Testa L; Pelzl L; Maleck C; Gawaz M; Gramlich M
J Mol Cell Cardiol; 2019 Jun; 131():12-19. PubMed ID: 30998980
[TBL] [Abstract][Full Text] [Related]
18. Antisense oligonucleotide-mediated exon skipping of CHRNA1 pre-mRNA as potential therapy for Congenital Myasthenic Syndromes.
Tei S; Ishii HT; Mitsuhashi H; Ishiura S
Biochem Biophys Res Commun; 2015 Jun; 461(3):481-6. PubMed ID: 25888793
[TBL] [Abstract][Full Text] [Related]
19. Enhanced exon-skipping induced by U7 snRNA carrying a splicing silencer sequence: Promising tool for DMD therapy.
Goyenvalle A; Babbs A; van Ommen GJ; Garcia L; Davies KE
Mol Ther; 2009 Jul; 17(7):1234-40. PubMed ID: 19455105
[TBL] [Abstract][Full Text] [Related]
20. A prospective study in the rational design of efficient antisense oligonucleotides for exon skipping in the DMD gene.
Pramono ZA; Wee KB; Wang JL; Chen YJ; Xiong QB; Lai PS; Yee WC
Hum Gene Ther; 2012 Jul; 23(7):781-90. PubMed ID: 22486275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]